Latest Articles

Publication Date
A Lipid Metabolism and Lysosome-based Risk Signature for Prognosis and Immune Response Prediction in Uterine Corpus Endometrial Carcinoma - Frontiers

A Lipid Metabolism and Lysosome-based Risk Signature for Prognosis and Immune Response Prediction in Uterine Corpus Endometrial Carcinoma Frontiers

Published: Aug. 18, 2025, 5:24 p.m.
Characterizing disease-associated microbiome signatures using matched... - researchgate.net

Characterizing disease-associated microbiome signatures using matched... researchgate.net

Published: July 17, 2025, 7:18 p.m.
Schoolboy's bank holiday petition gains over 20,000 signatures - Yahoo

Schoolboy's bank holiday petition gains over 20,000 signatures Yahoo

Published: June 30, 2025, 3 p.m.
ACR-368 OncoSignature Assay Receives FDA Breakthrough Device Designation for Endometrial Cancer - Pharmacy Times

ACR-368 OncoSignature Assay Receives FDA Breakthrough Device Designation for Endometrial Cancer Pharmacy Times

Published: Feb. 10, 2025, 2:34 p.m.
FDA Grants Breakthrough Device Designation to ACR-368 OncoSignature Assay for Endometrial Cancer - OncLive

FDA Grants Breakthrough Device Designation to ACR-368 OncoSignature Assay for Endometrial Cancer OncLive

Published: Feb. 5, 2025, 5:17 p.m.
Acrivon Therapeutics Announces FDA has Granted Breakthrough Device Designation for ACR-368 OncoSignature Assay for Endometrial Cancer - The Manila Times

Acrivon Therapeutics Announces FDA has Granted Breakthrough Device Designation for ACR-368 OncoSignature Assay for Endometrial Cancer The Manila Times

Published: Feb. 5, 2025, 1:07 p.m.
A machine learning-based immune response signature to facilitate prognosis prediction in patients with endometrial cancer | Scientific Reports - Nature.com

A machine learning-based immune response signature to facilitate prognosis prediction in patients with endometrial cancer | Scientific Reports Nature.com

Published: Dec. 28, 2024, 2:37 a.m.
A machine learning-based immune response signature to facilitate prognosis prediction in patients with endometrial cancer - Nature.com

A machine learning-based immune response signature to facilitate prognosis prediction in patients with endometrial cancer Nature.com

Published: Dec. 28, 2024, 2:37 a.m.
Identification of a disulfidptosis-related genes signature for diagnostic and immune infiltration characteristics in endometriosis | Scientific Reports - Nature.com

Identification of a disulfidptosis-related genes signature for diagnostic and immune infiltration characteristics in endometriosis | Scientific Reports Nature.com

Published: Oct. 29, 2024, 9:31 a.m.
Study unveils protein signatures for early detection of endometrial cancer in cervico-vaginal fluid - News-Medical.Net

Study unveils protein signatures for early detection of endometrial cancer in cervico-vaginal fluid News-Medical.Net

Published: March 26, 2024, 7 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!